AACC 2020: COVID-19 Paved Way For ‘Retailization,’ Innovation In Point-Of-Care Testing, Now What?
Executive Summary
A panel discussed opportunities and challenges in POC testing beyond the pandemic, including the consumer-centric health care environment and continued innovation.
You may also be interested in...
First COVID-19 At-Home Test That Doesn’t Require A Prescription Authorized By The FDA
Ellume Health’s COVID-19 Home Test isn’t just a relatively fast, accurate and easy-to-administer antigen diagnostic, but it’s also available over-the-counter, which greatly expands public access to such tests.
FDA Authorizes First Direct-To-Consumer COVID-19 Sample Collection Kit
LabCorp’s Pixel COVID-19 test home collection kit will be available over the counter through LabCorp’s website.
Antibody Testing During And After The Pandemic: Not All Tests Are Created Equal
While the main role of SARS-CoV-2 antibody testing is currently limited to determining exposure to the virus in populations, the scientific community is working hard to define the neutralizing properties of the antibodies detected, and the duration of the immune response. As a result, antibody testing could be here to stay for the long term for monitoring populations, testing vaccines and selecting patients for trials of a variety of new therapies to treat numerous conditions.